Newstral
Article
The Spokesman-Review on 2023-12-05 00:53
Obesity drugs' value explodes - Mon, 04 Dec 2023 PST
Related news
- Obesity drug investors get windfall after Roche buys into frenzy - Mon, 04 Dec 2023 PSTsyndication.washingtonpost.com
- Inflation has depleted pandemic-era savings for many Americans - Mon, 04 Dec 2023 PSTsyndication.washingtonpost.com
- Amgen is said to agree to buy Horizon at $26 billion value - Mon, 12 Dec 2022 PSTsyndication.washingtonpost.com
- Man sentenced to 20 years for drive-by shooting, witness tampering, drugs and more - Mon, 12 Dec 2022 PSTThe Spokesman-Review
- 'The nuclear weapon of drugs': Inslee, panel of experts talk Washington fentanyl epidemic - Mon, 04 Dec 2023 PSTThe Spokesman-Review
- Oregon 1st state to decriminalize possession of hard drugs - Mon, 01 Feb 2021 PSTThe Spokesman-Review
- Chrono24 CEO says Rolex certification move to boost sales - Mon, 05 Dec 2022 PSTsyndication.washingtonpost.com
- Hertz to settle most false-arrest claims for $168 million - Mon, 05 Dec 2022 PSTsyndication.washingtonpost.com
- Telescopes team up to forecast an alien storm on Titan - Mon, 05 Dec 2022 PSTThe New York Times
- U.S. stocks higher after Trump signs $900B aid package - Mon, 28 Dec 2020 PSTThe Spokesman-Review
- US plans diplomatic boycott of Beijing Winter Olympics - Mon, 06 Dec 2021 PSTThe Spokesman-Review
- Stocks slightly higher as traders return from holiday - Mon, 27 Dec 2021 PSTapnews.com
- Pandemic again forces delay in plans for next Davos meeting - Mon, 20 Dec 2021 PSTapnews.com
- What happens when patients stop obesity drugs like Wegovy?reviewjournal.com
- Reducing abortions - Mon, 24 Dec 2018 PSTThe Spokesman-Review
- Kathy Plonka - Mon, 05 Dec 2022 PSTThe Spokesman-Review
- aw_231205_lottos - Mon, 04 Dec 2023 PSTThe Spokesman-Review
- Washington records - Mon, 21 Dec 2020 PSTThe Spokesman-Review
- Hewitt's bias - Mon, 30 Dec 2019 PSTThe Spokesman-Review
- Washington records - Mon, 12 Dec 2022 PSTThe Spokesman-Review